---
layout: minimal-medicine
title: Phenindione
---

# Phenindione
### Generic Name
Phenindione

### Usage
Phenindione is a blood thinner (anticoagulant) medication primarily used to prevent and treat blood clots.  Its main application is in managing thromboembolic disorders, which are conditions involving blood clots that block blood vessels. This includes venous thromboembolism (blood clots in the veins, such as deep vein thrombosis or pulmonary embolism), and preventing systemic embolization (blood clots traveling through the bloodstream) in patients with atrial fibrillation (irregular heartbeat) or rheumatic heart disease.  It's also used as a preventative measure after the insertion of a prosthetic heart valve.

### Dosage
**Adult Dosage:**  Dosage is highly individualized and critically depends on regular monitoring of the International Normalized Ratio (INR), a blood test measuring clotting time.  

* **Initial Dose (Thromboembolic complications):** 200 mg orally on the first day, followed by 100 mg orally on the second day.
* **Maintenance Dose (Thromboembolic complications):** From the third day onward, the dose is adjusted based on INR test results. The usual maintenance range is 50-150 mg/day, but some individuals may require doses outside this range.  Heparin should be discontinued at least 6 hours before the first INR test after starting Phenindione, as heparin interferes with INR measurements.


**Pediatric Dosage:**  The safety and efficacy of Phenindione in children have not been established.

**Dosage Adjustments:**  Dosage adjustments are crucial and should always be made under the guidance of a healthcare professional based on regular INR monitoring.

* **Hepatic Impairment:**  Use with caution in patients with mild-to-moderate hepatic impairment.  Severe hepatic impairment contraindicates its use.  Close INR monitoring is essential.
* **Renal Impairment:**  Use with caution in patients with mild-to-moderate renal impairment; lower doses might be sufficient.  Severe renal impairment contraindicates its use. Close INR monitoring is essential.
* **Toxicity Management:**  If INR exceeds 4.5, the risk of major bleeding increases significantly.  An INR of 6 or higher necessitates reversal of anticoagulation. Treatment for excessive anticoagulation may involve stopping the medication temporarily, administering Vitamin K (1-10mg), fluid replacement, blood transfusions, and addressing the cause of bleeding.  In severe cases, prothrombin complex concentrate or fresh frozen plasma may be necessary.


### Side Effects
Common side effects may include:

* Diarrhea
* Nausea
* Vomiting
* Skin rash
* Purple toe syndrome

Less common but potentially serious side effects include:

* Bleeding (ranging from minor to life-threatening)
* Pancreatitis
* Liver damage (hepatitis, jaundice)
* Skin necrosis (tissue death)
* Blood disorders (agranulocytosis, leukopenia, thrombocytopenia)
* Allergic reactions


**Seek immediate medical attention if you experience any serious or unusual side effects.**

### How it Works
Phenindione is a vitamin K antagonist. It works by interfering with the liver's production of several clotting factors (factors II, VII, IX, and X, as well as proteins C and S) which are vital for blood clot formation. By inhibiting the production of these factors, Phenindione reduces blood clotting ability, preventing the formation of potentially dangerous clots.

### Precautions
**Contraindications:** Phenindione is contraindicated in several situations, including:

* Allergy to Phenindione or any formulation component.
* Hemorrhagic stroke.
* Significant bleeding.
* Within 72 hours of major surgery (high bleeding risk).
* Within 48 hours postpartum.
* Concurrent use with fibrinolytic drugs or other drugs significantly increasing bleeding risk.
* Severe renal or hepatic impairment.
* Bacterial endocarditis.
* Existing or potential hemorrhagic conditions.
* Uncontrolled hypertension.
* Pregnancy and breastfeeding.
* Hereditary disorders like galactose intolerance, lactase deficiency, or glucose-galactose malabsorption.


**Warnings and Precautions:**

* Increased risk of major or fatal bleeding, skin necrosis, calciphylaxis (a serious condition affecting blood vessels and skin), and hypersensitivity reactions.
* Use with caution in patients with active peptic ulcers, renal impairment, thyroid disease, genetic variations affecting Vitamin K metabolism (VKORC1 gene), and elderly individuals.
* Consistent vitamin K intake (through a balanced diet) is crucial to maintain effectiveness and avoid drastic changes in vitamin K-rich food intake.
* Concomitant use with cranberry juice may increase INR and bleeding risk.


**Drug Interactions:**  Phenindione's effects can be increased or decreased by many medications.  Important interactions include potentiation by drugs like allopurinol, cimetidine, and oral contraceptives, and antagonism by barbiturates and phenytoin.  Broad-spectrum antibiotics can also alter effectiveness by impacting gut flora that produce vitamin K.  Discuss all medications with your doctor before starting Phenindione.

### FAQs

* **Q: How long does it take for Phenindione to work?** A: The onset of action varies, but therapeutic effects are usually seen within a few days.  Regular INR monitoring is crucial.

* **Q: How should I store Phenindione?** A: Store as directed on the product label, typically in a cool, dry place away from light and moisture.

* **Q: What should I do if I miss a dose?** A:  Do not double up on doses. Contact your doctor or pharmacist for guidance.

* **Q: Can I drink alcohol while taking Phenindione?** A:  Alcohol may increase bleeding risk.  Limit or avoid alcohol consumption while taking Phenindione. Discuss this with your doctor.

* **Q: What are the signs of bleeding while on Phenindione?** A: Bleeding can range from easy bruising to heavy bleeding, blood in urine or stool, unusual nosebleeds, or prolonged bleeding from cuts.  Contact your doctor immediately if you notice any unusual bleeding.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult with a healthcare professional before starting, stopping, or changing any medication.  Individual dosage and monitoring needs will vary depending on health status, age, and other factors.
